제품 > 재조합 단백질

Recombinant SARS-COV-2 Nucleocapsid(D63G, R203M, D377Y) Protein (RP01474LQ)

Bioactivityvalidated

Datasheet

Overview

Product nameRecombinant SARS-COV-2 Nucleocapsid(D63G, R203M, D377Y) Protein
Catalog No.RP01474LQ
DescriptionRecombinant SARS-COV-2 Nucleocapsid(D63G, R203M, D377Y) Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ser2-Ala419(D63G, R203M, D377Y)) of sars-cov-2 Nucleocapsid(D63G, R203M, D377Y) (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus.
Bio-ActivityMeasured by its binding ability in a functional ELISA.Immobilized SARS-CoV-2 Envelope at 2 μg/mL (100 μL/well) can bind SARS-COV-2 Nucleocapsid with a linear range of 0.01-30 ng/mL.
Purity> 95% by SDS-PAGE.> 95% by HPLC.
Endotoxin<0.1EU/μg
FormulationSupplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0.
SpeciesSARS-COV-2
Calculated MW46.30 kDa
SynonymNucleoprotein
Expression HostE. coli
TagN-his
Gene ID
StorageStore at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

* For research use only. Not for therapeutic or diagnostic purposes.

용량을 선택하세요
문의하기